Tonix Pharmaceuticals Holding Corp (TNXP)
Financing Cash Flow
$213.05M
TTM · Period ending: · USD
TNXP Financing Cash Flow
Latest reported$213.05Mperiod ending
Latest reported$213.05Mperiod ending
TNXP TTM Cash from Financing ($50.00K → $213.05M)
TTM financing cash flow
High-resolution chart · PNG
TNXP financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 213,051,243 | |
| 190,539,243 | |
| 219,867,243 | |
| 245,878,243 | |
| 188,585,000 | |
| 184,617,000 | |
| 134,872,000 | |
| 90,432,000 | |
| 53,801,000 | |
| 47,805,000 | |
| 36,517,000 | |
| 3,685,404 | |
| -7,213,596 | |
| 63,934,404 | |
| 88,497,404 | |
| 124,382,000 | |
| 166,968,000 | |
| 116,840,000 | |
| 212,487,000 | |
| 208,579,000 | |
| 190,687,000 | |
| 203,058,000 | |
| 123,105,000 | |
| 91,191,000 | |
| 75,606,000 | |
| 41,606,000 | |
| 12,919,000 | |
| 22,161,000 | |
| 20,567,000 | |
| 23,077,000 | |
| 23,539,000 | |
| 7,470,000 | |
| 4,581,000 | |
| 17,949,000 | |
| 18,519,000 | |
| 22,258,000 | |
| 26,115,000 | |
| 21,600,000 | |
| 20,498,000 | |
| 15,641,000 | |
| 30,477,000 | |
| 18,640,000 | |
| 47,694,000 | |
| 47,997,000 | |
| 36,674,000 | |
| 36,859,000 | |
| 53,217,000 | |
| 57,235,000 | |
| 60,087,000 | |
| 60,362,000 | |
| 14,950,000 | |
| 13,884,000 | |
| 3,661,000 | |
| 3,255,000 | |
| 7,492,895 | |
| 6,850,895 | |
| 7,394,895 | |
| 7,659,895 | |
| 3,724,999 | |
| 1,121,999 | |
| 579,999 | |
| 314,999 | |
| 12,000 | |
| 2,000 | |
| 0 | |
| 0 | |
| 0 | |
| 7,000 | |
| 29,000 | |
| 50,000 | |
| 50,000 |